Mary Kay Fenton
2010 - Achillion Pharmaceuticals
In 2010, Mary Kay Fenton earned a total compensation of $788.1K as Senior Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 103% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $90,406 |
|---|---|
| Option Awards | $426,760 |
| Salary | $263,222 |
| Other | $7,673 |
| Total | $788,061 |
Fenton received $426.8K in option awards, accounting for 54% of the total pay in 2010.
Fenton also received $90.4K in non-equity incentive plan, $263.2K in salary and $7.7K in other compensation.
Rankings
In 2010, Mary Kay Fenton's compensation ranked 6,172nd out of 10,439 executives tracked by ExecPay. In other words, Fenton earned more than 40.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,172 out of 10,439 | 41st |
Division Manufacturing | 2,220 out of 3,838 | 42nd |
Major group Chemicals And Allied Products | 489 out of 921 | 47th |
Industry group Drugs | 305 out of 680 | 55th |
Industry Pharmaceutical Preparations | 228 out of 481 | 53rd |
Source: SEC filing on April 12, 2013.
Fenton's colleagues
We found five more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2010.
2010
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
2010
Milind Deshpande
Achillion Pharmaceuticals
Chief Scientific Officer
2010
Joseph Truitt
Achillion Pharmaceuticals
Senior Vice President and Chief Commercial Officer
2010
Gautam Shah
Achillion Pharmaceuticals
Executive Vice President and Chief Compliance Officer
2010
Elizabeth Olek
Achillion Pharmaceuticals